Delivery Order SPE2DB25D3201-SPE2DB25FNSSK

Award Date 4/25/25
Potential Completion Date 4/28/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $16,706.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication Sprycel 100 mg tablet, and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,720.30 firm fixed-price delivery order, identified as SPE2DB22D1103|SPE2DB25FTKB1, is for the supply of Sprycel 80 mg tablets. The contract has an ultimate completion date of April 11, 2025 and is not set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Sprycel 70 mg tablets. The contract is a Delivery Order valued at $9,190.91 with a firm fixed price and an ultimate completion date of May 22, 2024. Amerisourcebergen, through its Corporate Office division, has extensive experience fulfilling government contracts for a wide range of prescription medications, over-the-counter drugs, and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Sprycel 100 mg tablets. The contract has a ceiling value of $16,276.12 and is a firm fixed-price delivery order. It does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Sprycel 100 mg tablets. The $16,006.11 firm-fixed-price delivery order contract has a completion date of June 21, 2024. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA to provide a comprehensive...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $29,285.55 firm fixed-price delivery order is for the pharmaceutical product Sprycel 100 mg Tablet 30s. This order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is a Firm Fixed Price delivery order for the pharmaceutical product Sprycel 140 mg tablets, with a ceiling value of $12,028.56 and a performance period through April 1, 2024. The contract does not have any set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $55,285.69 delivery order contract is for the supply of 60-count tablets of Sprycel 50mg, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of September 18, 2024. AmerisourceBergen, through its Corporate Office division, will provide the requested pharmaceutical product to support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order (SPE2DX15D1053|SPE2DX25F6CTA) valued at $36,158.34 for the supply of the prescription drug Sprycel. The contract, which has a completion date of November 4, 2024, was awarded on November 1, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. This award is not designated as a set-aside contract. Amerisourcebergen holds a...
This federal contract award with the Defense Logistics Agency (DLA) is for the delivery of Sprycel 100 MG Tablets in a 30-count package. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical supplier to the U.S. federal government, on June 28, 2024. The firm-fixed-price delivery order has a ceiling value of $26,750.22 and an ultimate completion date of July 1, 2024. This contract is not designated as a set-aside. Amerisourcebergen, through its Corporate Office Division,...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNSSK
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sprycel 140 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $12,240.50 and a performance period through April 28, 2025.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard. The contract award described is not designated as a set-aside.

Generated 7/25/25, 11:21 AM